49th Annual Radiation Oncology Research Seminar

The 49th Annual Research Seminar featured three concurrent programs on February 22: the Radiation Therapists’ Seminar, the Oncology Nursing Seminar, and the Radiation Oncology Research Seminar.

The event, which took place February 22-23, 2019 at the Hilton University of Florida Conference Center, assisted participants in defining optimal treatment approaches, producing the best plans, employing first-rate techniques, providing healing experiences for our patients, assessing outcomes, and developing new treatment approaches, providing invaluable information to faculty and residents from several educational institutions as well as professionals in private practice.

Keynote Speaker

The 2019 Keynote Speaker was David E. Wazer,  MD, FACRO, FABS, FACR, FASTRO, director of the Lifespan Cancer Institute of Rhode Island, The Miriam and Newport hospitals, as well as radiation oncologist-in-chief at Rhode Island Hospital. He is professor and chairman of the departments of radiation oncology at both The Warren Alpert Medical School of Brown University and Tufts University School of Medicine.

Dr. Wazer is an internationally recognized expert in the application of new technology in the field of radiation oncology. He has published more than 200 scientific articles, written several books, and is also editor-in-chief of the American Journal of Clinical Oncology. His specialties include postlumpectomy radiotherapy for breast preservation; melanomas, including ocular melanoma; gastrointestinal carcinoma; and stereotactic radiotherapy and radiosurgery.

Wazer earned his medical degree (with honors) from the New York University School of Medicine, New York, NY, and also completed a research fellowship in neurochemistry at New York University. Dr. Wazer obtained his clinical training in internal medicine at Brown University and in radiation oncology at Tufts University. His clinical research interests include the study of the efficacy, toxicity, and cost/utility analysis of image-guided radiation therapy, partial breast irradiation, electronic brachytherapy and hyperthermia. He is actively involved in the development of clinical trials for cancers of the breast, skin, gastrointestinal tract and lung.

Dr. Wazer is a fellow of the American Society for Radiation Oncology and the American College of Radiation Oncology and a member of the Radiation Research Society, American Society of Clinical Oncology, the American College of Radiology, the American Radium Society, the American Association for the Advancement of Science and the American Brachytherapy Society.

Seminar Topics

Topics included: Survival outcomes after radiotherapy treatment for head and neck, breast, thyroid, skin, and genitourinary cancers; sarcomas; lymphomas; and central nervous system tumors, among other disease sites | Quality of life, and its clinical assessment, in patients who receive radiotherapy | Proton therapy techniques and outcomes in adult and pediatric tumors | Treatment toxicities, emergent patient needs, and survivorship.

Presenters will typically present the results of IRB-approved studies conducted throughout the year that focus on monitoring and analyzing the outcomes of patients who have received radiotherapy at UF.

Objectives

This research seminar helped participants to:

  1. Describe techniques and results of treatment of head and neck, pediatric cancers, lung cancer, and other tumors at the University of Florida Department of Radiation Oncology and the University of Florida Proton Therapy Institute.
  2. Explain treatment methods to manage treatment side effects and reduce the occurrence of late complications of treatment.
  3. Recognize and interpret the success rates UF is experiencing with its radiotherapy techniques

Accreditation

The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit

The University of Florida College of Medicine designates this live activity for a maximum of 11 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This course was approved by the Florida Nurses Association (FL# 50-3103) for 8.0 nurse contact hours.

Past Meetings

Learn more about our past meetings.

NATIONALLY RANKED

U.S. News and World Report

Nationally ranked in 6 adult specialties and 6 pediatric specialties and rated high performing in 4 adult specialties and 5 procedures and conditions.

Award